Ontology highlight
ABSTRACT: Background
Glycation of high-density lipoprotein (HDL) decreases its ability to induce cyclooxygenase-2 (COX-2) expression and prostacyclin I-2 (PGI-2) release in endothelial cells. Whether lipid content of HDL, especially sphingosine-1-phosphate (S1P), plays any specific role in restoring the protective function of HDL in type 2 diabetes mellitus (T2DM) is still unknown.Methods and results
Immunochemical techniques demonstrated that glycated HDL loses its protective function of regulating COX-2 expression compared with diabetic HDL. We proved that the lipid content, especially phospholipid content differed between diabetic HDL and glycated HDL. Levels of HDL-c-bound S1P were increased in T2DM compared with control subjects as detected by UPLC-MS/MS (HDL-c-bound S1P in control subjects vs. T2DM: 309.1?±?13.71 pmol/mg vs. 382.1?±?24.45 pmol/mg, P?Conclusion/significanceS1P harbored on HDL is the main factor which restores its protective function in endothelial cells in T2DM. S1P and its receptors are potential therapeutic targets in ameliorating the vascular dysfunction in T2DM.
SUBMITTER: Tong X
PROVIDER: S-EPMC4021293 | biostudies-literature | 2014 Apr
REPOSITORIES: biostudies-literature
Tong Xunliang X Lv Pu P Mathew Anna V AV Liu Donghui D Niu Chenguang C Wang Yan Y Ji Liang L Li Jizhao J Fu Zhiwei Z Pan Bing B Pennathur Subramaniam S Zheng Lemin L Huang Yining Y
Cardiovascular diabetology 20140421
<h4>Background</h4>Glycation of high-density lipoprotein (HDL) decreases its ability to induce cyclooxygenase-2 (COX-2) expression and prostacyclin I-2 (PGI-2) release in endothelial cells. Whether lipid content of HDL, especially sphingosine-1-phosphate (S1P), plays any specific role in restoring the protective function of HDL in type 2 diabetes mellitus (T2DM) is still unknown.<h4>Methods and results</h4>Immunochemical techniques demonstrated that glycated HDL loses its protective function of ...[more]